After Gasoline, China's Oil Refiners Face a Jet Fuel Glut
In the post-pandemic period, as flights returned to the skies, jet fuel was a boon for domestic refiners struggling with a sputtering economic recovery, the electrification of the car fleet and trucks turning to alternatives like liquefied natural gas. Refiners piled into aviation, using up feedstock that in the past would have gone into road-transport fuels.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
29 minutes ago
- Yahoo
Pony AI (PONY) Expands Robotaxi Services to Shanghai—Analysts Stay Bullish
Pony AI Inc. (NASDAQ:PONY) is one of the . On July 30, Goldman Sachs analyst Allen Chang maintained a 'Buy' rating on the stock and set a price target of $26.00. The firm is optimistic about the company's strategic advancements and growth potential in the autonomous vehicle sector. Pony AI's latest commercialization efforts have borne fruit, with the company having obtained a permit to provide fully driverless commercial Robotaxi services in the Shanghai Pudong New Area. The company has already been operating in major tier-1 cities like Beijing, Shenzhen, and Guangzhou, and now that it has expanded into Shanghai, it has strengthened its market presence and revenue potential further. A fleet of autonomous vehicles driving down a sun-drenched highway. The Chinese autonomous vehicle technology company is religiously devoted to technological innovation, as evident from its full time Robotaxi testing across areas such as Beijing, Shenzhen, and Guangzhou. Meanwhile, the Gen-7 Robotaxi manufactured in collaboration with major automotive manufacturers' further promises lower hardware costs and enhanced software capabilities. Pony AI Inc. (NASDAQ:PONY) specializes in autonomous mobility, offering AI-driven robotruck and robotaxi services, intelligent driving software, and vehicle integration solutions. While we acknowledge the potential of PONY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Must-Watch AI Stocks on Wall Street and Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Bloomberg
an hour ago
- Bloomberg
Modi Renews Call for Indians to Buy Local Products Amid Tariffs
Indian Prime Minister Narendra Modi intensified his push to prioritize locally made products, amid global economic instability in the wake of US trade tariffs. Modi urged citizens to buy, sell and promote Indian products, citing global economic uncertainty but without referring to US tariffs.
Yahoo
an hour ago
- Yahoo
Alpha IVF Group Berhad Full Year 2025 Earnings: Misses Expectations
Alpha IVF Group Berhad (KLSE:ALPHA) Full Year 2025 Results Key Financial Results Revenue: RM176.8m (up 5.5% from FY 2024). Net income: RM57.5m (up 8.5% from FY 2024). Profit margin: 33% (in line with FY 2024). EPS: RM0.012 (in line with FY 2024). We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. All figures shown in the chart above are for the trailing 12 month (TTM) period Alpha IVF Group Berhad Revenues and Earnings Miss Expectations Revenue missed analyst estimates by 8.9%. Earnings per share (EPS) also missed analyst estimates by 13%. The primary driver behind last 12 months revenue was the Malaysia segment contributing a total revenue of RM157.2m (89% of total revenue). The largest operating expense was General & Administrative costs, amounting to RM33.1m (67% of total expenses). Explore how ALPHA's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 25% p.a. on average during the next 3 years, compared to a 8.6% growth forecast for the Healthcare industry in Malaysia. Performance of the Malaysian Healthcare industry. The company's shares are up 5.5% from a week ago. Risk Analysis We don't want to rain on the parade too much, but we did also find 2 warning signs for Alpha IVF Group Berhad (1 makes us a bit uncomfortable!) that you need to be mindful of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
